Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients

Greiner W, Rasch A, Koehler D, Salzberger B, Faetkenheuer G, Leidig M (2007)
CLINICAL MICROBIOLOGY AND INFECTION 13(3): 264-268.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor/in
; ; ; ; ;
Abstract / Bemerkung
The main aim of this study was to evaluate the clinical outcome and costs of nosocomial and community-acquired methicillin-susceptible Staphylococcus aureus (MSSA) or methicillin-resistant S. aureus (MRSA) bloodstream infection (BSI) in patients undergoing haemodialysis. A multicentre retrospective study was conducted that included 109 patients with end-stage renal disease and S. aureus BSI who were hospitalised in three German centres between 1999 and 2005. Nosocomial and community-acquired infections were analysed separately with regard to costs and outcome. Forty-nine (45%) patients had nosocomial infection. Compared to patients with community-acquired infection, these patients were more likely to have had BSI caused by MRSA (40.8% vs. 13.3%, p < 0.05). BSI was the initial reason for admission for 33 (55%) patients who had community-acquired infection. The mean length of hospitalisation was 24 days for patients with community-acquired infection and 51 days for patients with nosocomial infection (p < 0.05). Costs per treatment episode were 20 024 Euros for nosocomial infection vs. 9554 Euros for community-acquired infection (p < 0.05). The average treatment costs for patients with MSSA BSI were < 50% of those for patients with MRSA BSI (10 573 vs. 24 931 Euros, p < 0.05). S. aureus BSI is an underlying cause of substantial health risk and high morbidity among the haemodialysis-dependent population, who are already at high-risk for other reasons. This study also highlighted differences according to the source of BSI, including costs arising from hospitalisation and treatment.
Stichworte
haemodialysis; MRSA; renal failure; Staphyloccocus aureus; bacteraemia; cost of illness
Erscheinungsjahr
2007
Zeitschriftentitel
CLINICAL MICROBIOLOGY AND INFECTION
Band
13
Ausgabe
3
Seite(n)
264-268
ISSN
1198-743X
eISSN
1469-0691
Page URI
https://pub.uni-bielefeld.de/record/1595895

Zitieren

Greiner W, Rasch A, Koehler D, Salzberger B, Faetkenheuer G, Leidig M. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. CLINICAL MICROBIOLOGY AND INFECTION. 2007;13(3):264-268.
Greiner, W., Rasch, A., Koehler, D., Salzberger, B., Faetkenheuer, G., & Leidig, M. (2007). Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. CLINICAL MICROBIOLOGY AND INFECTION, 13(3), 264-268. doi:10.1111/j.1469-0691.2006.01622.x
Greiner, W., Rasch, A., Koehler, D., Salzberger, B., Faetkenheuer, G., and Leidig, M. (2007). Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. CLINICAL MICROBIOLOGY AND INFECTION 13, 264-268.
Greiner, W., et al., 2007. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. CLINICAL MICROBIOLOGY AND INFECTION, 13(3), p 264-268.
W. Greiner, et al., “Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients”, CLINICAL MICROBIOLOGY AND INFECTION, vol. 13, 2007, pp. 264-268.
Greiner, W., Rasch, A., Koehler, D., Salzberger, B., Faetkenheuer, G., Leidig, M.: Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients. CLINICAL MICROBIOLOGY AND INFECTION. 13, 264-268 (2007).
Greiner, Wolfgang, Rasch, A., Koehler, D., Salzberger, B., Faetkenheuer, G., and Leidig, M. “Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients”. CLINICAL MICROBIOLOGY AND INFECTION 13.3 (2007): 264-268.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 17391380
PubMed | Europe PMC

Suchen in

Google Scholar